EchoNext, a new AI tool cleared by the FDA, will let doctors use an EKG to easily screen patients for structural heart diseases.

EchoNext, a new AI tool cleared by the FDA, will let doctors use an EKG to easily screen patients for structural heart diseases.

In this edition of STAT Health Tech: OpenEvidence adds AI to detect heart disease, and Cadence raises $100 million, and more.